ArticleJournal of gastroenterology and hepatology2022

Hyperactive neutrophil chemotaxis contributes to anti-tumor necrosis factor-α treatment resistance in inflammatory bowel disease.

Tung On Yau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.